Rapid Profile Viscometer Devices And Methods

    公开(公告)号:US20230404411A1

    公开(公告)日:2023-12-21

    申请号:US18459947

    申请日:2023-09-01

    IPC分类号: A61B5/02 G01N11/08

    CPC分类号: A61B5/02035 G01N11/08

    摘要: Using whole blood viscosity (WBV) data collected at various shear rates in conjunction with other clinically relevant information—such as age, gender, and other medical history information—one can generate information indicative of a current or physiological condition of a subject. Such generation can be accomplished using machine learning, such as a trained algorithm. One can also train an algorithm using WBV and other clinically relevant information. The described approaches allow for early detection and treatment of conditions, such as sepsis, as well as the evaluation of a treatment or treatments administered to a patient in need.

    Rapid profile viscometer devices and methods

    公开(公告)号:US11747252B2

    公开(公告)日:2023-09-05

    申请号:US17497292

    申请日:2021-10-08

    IPC分类号: G01N11/04

    CPC分类号: G01N11/04

    摘要: Provided are apparatuses and methods for rapid viscometry of whole blood, plasma, and/or whole blood during coagulation. The disclosed technology measures the blood viscosity through the full range of flow rates found in the cardio-vascular system. This in vitro test can be performed on fresh or anticoagulated whole blood to predict the flow properties (e.g., viscosity) anywhere in the body from the aorta to the deep veins of the leg. The result is a flow-rate dependent blood viscosity curve (viscosity profile) that helps the clinician predict and manage the patient's vulnerability to thrombosis and embolism, which is of particular relevance to COVID-19 patients and/or ICU patients.

    Rapid Profile Viscometer Devices And Methods

    公开(公告)号:US20220196533A1

    公开(公告)日:2022-06-23

    申请号:US17497292

    申请日:2021-10-08

    IPC分类号: G01N11/04

    摘要: Provided are apparatuses and methods for rapid viscometry of whole blood, plasma, and/or whole blood during coagulation. The disclosed technology measures the blood viscosity through the full range of flow rates found in the cardio-vascular system. This in vitro test can be performed on fresh or anticoagulated whole blood to predict the flow properties (e.g., viscosity) anywhere in the body from the aorta to the deep veins of the leg. The result is a flow-rate dependent blood viscosity curve (viscosity profile) that helps the clinician predict and manage the patient's vulnerability to thrombosis and embolism, which is of particular relevance to COVID-19 patients and/or ICU patients.